No Data
No Data
Express News | Cyclo Therapeutics: Trappsol Cyclo™ Demonstrated to Be Well Tolerated in Ongoing Substudy With Safety Profile Consistent With That of Completed Phases
Express News | Cyclo Therapeutics Presents Encouraging Preliminary Safety Data From Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (Npc1)
Cyclo Therapeutics Presents Encouraging Preliminary Safety Data From Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1)
This Hershey Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
Maxim Group Downgrades Cyclo Therapeutics(CYTH.US) to Hold Rating
Maxim Downgrades Cyclo Therapeutics to Hold From Buy
No Data
No Data